Skip to content
  • (312) 598-2610
  • info@ipfdalaw.com
  • 109 Symonds Drive, #174, Hinsdale, IL 60522-0174
Untitled design (7)
  • About
    • Detailed Description
    • Our Team
    • Fee Structures
  • Services
    • Patent Litigation
    • Commercial Litigation
    • False Advertising & Unfair Competition
    • Generic Drugs
    • Branded Drugs and 505(b)(2)
    • Medical Devices
    • FDA/Exclusivity/GMP
    • Contracts & Licensing
    • Government Investigations
  • News
  • Videos
  • Recent Cases
  • Contact Us
  • About
    • Detailed Description
    • Our Team
    • Fee Structures
  • Services
    • Patent Litigation
    • Commercial Litigation
    • False Advertising & Unfair Competition
    • Generic Drugs
    • Branded Drugs and 505(b)(2)
    • Medical Devices
    • FDA/Exclusivity/GMP
    • Contracts & Licensing
    • Government Investigations
  • News
  • Videos
  • Recent Cases
  • Contact Us
中文

Day: October 15, 2024

Proving Patent Infringement – Double Counting Pharmaceutical Ingredients When One Element Satisfies Two Claim Limitations

By: Shashank Upadhye Introduction         Typically, patent infringement requires comparing the patent claims to the accused device or process. Patent claims are stylized differently but the import is the same; there must be some correspondence between what is claimed compared to the accused device or process. A simplistic way is to envision a so-called […]

Patents
Hatch-Waxman Litigation
Trade Secrets
Antitrust/Unfair Competition
FDA Counseling
Branded/Generic/ 505(b)(2)
Life Cycles
Contracts Licensing
Freedom to Operate

Quick Contact

Address

  • 109 Symonds Drive, #174, Hinsdale, IL 60522-0174
  • (312) 598-2610
  • info@ipfdalaw.com

Ⓒ 2021 - IPFDA law All Rights Are Reserved